Marsh & Mclennan Companies (MRSH) EBITDA Margin (2009 - 2026)

Marsh & Mclennan Companies (MRSH) has reported EBITDA Margin for 18 consecutive years, with 25.65% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin fell 58.0% year-over-year to 25.65%; the trailing twelve-month figure through Jun 2026 stood at 21.62% (down 196.0% YoY), and the FY2025 full-year result was 23.06%, down 72.0% from the prior year.
• EBITDA Margin climbed to 25.65% in Q2 2026 per MRSH's latest filing, from 23.09% in the prior quarter.
• Across five years, EBITDA Margin topped out at 29.74% in Q1 2024 and bottomed at 13.54% in Q4 2022.
• Historically, EBITDA Margin has averaged 22.69% across 5 years, with a median of 23.94% in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin plunged 565 bps in 2022, then jumped 632 bps in 2023.
• Over 5 years, EBITDA Margin stood at 13.54% in 2022, then surged by 47 bps to 19.86% in 2023, then fell by 5 bps to 18.82% in 2024, then retreated by 2 bps to 18.48% in 2025, then jumped by 39 bps to 25.65% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 25.65%, 23.09%, and 18.48% for Q2 2026, Q1 2026, and Q4 2025 respectively.